The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.
The global Aprotinin market was valued at US$ 168400 million in 2023 and is anticipated to reach US$ 231570 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
Global Aprotinin key players include Sigma-Aldrich, BeiJing Geyuantianrun Bio-tech, Cayman Chemical, Taj Pharmaceuticals Limited, etc. Global top four manufacturers hold a share over 25%.
India is the largest market, with a share about 20%, followed by China, and North America, both have a share about 35 percent.
In terms of product, Aprotinin (From bovine lung) is the largest segment, with a share nearly 80%. And in terms of application, the largest application is Pharmaceuticals, followed by Scientific Research and Experiment.
This report aims to provide a comprehensive presentation of the global market for Aprotinin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aprotinin.
Report Scope
The Aprotinin market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aprotinin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aprotinin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sigma-Aldrich
BeiJing Geyuantianrun Bio-tech
Cayman Chemical
Taj Pharmaceuticals Limited
Guangdong Techpool Bio-pharma
Dadeli
A.S.Joshi&Company
Enzymeking Biotechnology
AdooQ BioScience
ProSpec
Yaxin Biotechnology
AMRESCO
PanReac AppliChem
Runhao
Segment by Type
Aprotinin (From bovine lung)
Recombinant Aprotinin
Segment by Application
Pharmaceuticals
Scientific Research and Experiment
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aprotinin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aprotinin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.
The global Aprotinin market was valued at US$ 168400 million in 2023 and is anticipated to reach US$ 231570 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
Global Aprotinin key players include Sigma-Aldrich, BeiJing Geyuantianrun Bio-tech, Cayman Chemical, Taj Pharmaceuticals Limited, etc. Global top four manufacturers hold a share over 25%.
India is the largest market, with a share about 20%, followed by China, and North America, both have a share about 35 percent.
In terms of product, Aprotinin (From bovine lung) is the largest segment, with a share nearly 80%. And in terms of application, the largest application is Pharmaceuticals, followed by Scientific Research and Experiment.
This report aims to provide a comprehensive presentation of the global market for Aprotinin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aprotinin.
Report Scope
The Aprotinin market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aprotinin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aprotinin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sigma-Aldrich
BeiJing Geyuantianrun Bio-tech
Cayman Chemical
Taj Pharmaceuticals Limited
Guangdong Techpool Bio-pharma
Dadeli
A.S.Joshi&Company
Enzymeking Biotechnology
AdooQ BioScience
ProSpec
Yaxin Biotechnology
AMRESCO
PanReac AppliChem
Runhao
Segment by Type
Aprotinin (From bovine lung)
Recombinant Aprotinin
Segment by Application
Pharmaceuticals
Scientific Research and Experiment
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aprotinin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aprotinin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Aprotinin Market Overview
1.1 Product Overview and Scope of Aprotinin
1.2 Aprotinin Segment by Type
1.2.1 Global Aprotinin Market Value Comparison by Type (2024-2030)
1.2.2 Aprotinin (From bovine lung)
1.2.3 Recombinant Aprotinin
1.3 Aprotinin Segment by Application
1.3.1 Global Aprotinin Market Value by Application: (2024-2030)
1.3.2 Pharmaceuticals
1.3.3 Scientific Research and Experiment
1.4 Global Aprotinin Market Size Estimates and Forecasts
1.4.1 Global Aprotinin Revenue 2019-2030
1.4.2 Global Aprotinin Sales 2019-2030
1.4.3 Global Aprotinin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Aprotinin Market Competition by Manufacturers
2.1 Global Aprotinin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Aprotinin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Aprotinin Average Price by Manufacturers (2019-2024)
2.4 Global Aprotinin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Aprotinin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aprotinin, Product Type & Application
2.7 Aprotinin Market Competitive Situation and Trends
2.7.1 Aprotinin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Aprotinin Players Market Share by Revenue
2.7.3 Global Aprotinin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Aprotinin Retrospective Market Scenario by Region
3.1 Global Aprotinin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Aprotinin Global Aprotinin Sales by Region: 2019-2030
3.2.1 Global Aprotinin Sales by Region: 2019-2024
3.2.2 Global Aprotinin Sales by Region: 2025-2030
3.3 Global Aprotinin Global Aprotinin Revenue by Region: 2019-2030
3.3.1 Global Aprotinin Revenue by Region: 2019-2024
3.3.2 Global Aprotinin Revenue by Region: 2025-2030
3.4 North America Aprotinin Market Facts & Figures by Country
3.4.1 North America Aprotinin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Aprotinin Sales by Country (2019-2030)
3.4.3 North America Aprotinin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Aprotinin Market Facts & Figures by Country
3.5.1 Europe Aprotinin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Aprotinin Sales by Country (2019-2030)
3.5.3 Europe Aprotinin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aprotinin Market Facts & Figures by Country
3.6.1 Asia Pacific Aprotinin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Aprotinin Sales by Country (2019-2030)
3.6.3 Asia Pacific Aprotinin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Aprotinin Market Facts & Figures by Country
3.7.1 Latin America Aprotinin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Aprotinin Sales by Country (2019-2030)
3.7.3 Latin America Aprotinin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Aprotinin Market Facts & Figures by Country
3.8.1 Middle East and Africa Aprotinin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Aprotinin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Aprotinin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Aprotinin Sales by Type (2019-2030)
4.1.1 Global Aprotinin Sales by Type (2019-2024)
4.1.2 Global Aprotinin Sales by Type (2025-2030)
4.1.3 Global Aprotinin Sales Market Share by Type (2019-2030)
4.2 Global Aprotinin Revenue by Type (2019-2030)
4.2.1 Global Aprotinin Revenue by Type (2019-2024)
4.2.2 Global Aprotinin Revenue by Type (2025-2030)
4.2.3 Global Aprotinin Revenue Market Share by Type (2019-2030)
4.3 Global Aprotinin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Aprotinin Sales by Application (2019-2030)
5.1.1 Global Aprotinin Sales by Application (2019-2024)
5.1.2 Global Aprotinin Sales by Application (2025-2030)
5.1.3 Global Aprotinin Sales Market Share by Application (2019-2030)
5.2 Global Aprotinin Revenue by Application (2019-2030)
5.2.1 Global Aprotinin Revenue by Application (2019-2024)
5.2.2 Global Aprotinin Revenue by Application (2025-2030)
5.2.3 Global Aprotinin Revenue Market Share by Application (2019-2030)
5.3 Global Aprotinin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sigma-Aldrich
6.1.1 Sigma-Aldrich Corporation Information
6.1.2 Sigma-Aldrich Description and Business Overview
6.1.3 Sigma-Aldrich Aprotinin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sigma-Aldrich Aprotinin Product Portfolio
6.1.5 Sigma-Aldrich Recent Developments/Updates
6.2 BeiJing Geyuantianrun Bio-tech
6.2.1 BeiJing Geyuantianrun Bio-tech Corporation Information
6.2.2 BeiJing Geyuantianrun Bio-tech Description and Business Overview
6.2.3 BeiJing Geyuantianrun Bio-tech Aprotinin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BeiJing Geyuantianrun Bio-tech Aprotinin Product Portfolio
6.2.5 BeiJing Geyuantianrun Bio-tech Recent Developments/Updates
6.3 Cayman Chemical
6.3.1 Cayman Chemical Corporation Information
6.3.2 Cayman Chemical Description and Business Overview
6.3.3 Cayman Chemical Aprotinin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cayman Chemical Aprotinin Product Portfolio
6.3.5 Cayman Chemical Recent Developments/Updates
6.4 Taj Pharmaceuticals Limited
6.4.1 Taj Pharmaceuticals Limited Corporation Information
6.4.2 Taj Pharmaceuticals Limited Description and Business Overview
6.4.3 Taj Pharmaceuticals Limited Aprotinin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Taj Pharmaceuticals Limited Aprotinin Product Portfolio
6.4.5 Taj Pharmaceuticals Limited Recent Developments/Updates
6.5 Guangdong Techpool Bio-pharma
6.5.1 Guangdong Techpool Bio-pharma Corporation Information
6.5.2 Guangdong Techpool Bio-pharma Description and Business Overview
6.5.3 Guangdong Techpool Bio-pharma Aprotinin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Guangdong Techpool Bio-pharma Aprotinin Product Portfolio
6.5.5 Guangdong Techpool Bio-pharma Recent Developments/Updates
6.6 Dadeli
6.6.1 Dadeli Corporation Information
6.6.2 Dadeli Description and Business Overview
6.6.3 Dadeli Aprotinin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dadeli Aprotinin Product Portfolio
6.6.5 Dadeli Recent Developments/Updates
6.7 A.S.Joshi&Company
6.6.1 A.S.Joshi&Company Corporation Information
6.6.2 A.S.Joshi&Company Description and Business Overview
6.6.3 A.S.Joshi&Company Aprotinin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 A.S.Joshi&Company Aprotinin Product Portfolio
6.7.5 A.S.Joshi&Company Recent Developments/Updates
6.8 Enzymeking Biotechnology
6.8.1 Enzymeking Biotechnology Corporation Information
6.8.2 Enzymeking Biotechnology Description and Business Overview
6.8.3 Enzymeking Biotechnology Aprotinin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Enzymeking Biotechnology Aprotinin Product Portfolio
6.8.5 Enzymeking Biotechnology Recent Developments/Updates
6.9 AdooQ BioScience
6.9.1 AdooQ BioScience Corporation Information
6.9.2 AdooQ BioScience Description and Business Overview
6.9.3 AdooQ BioScience Aprotinin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AdooQ BioScience Aprotinin Product Portfolio
6.9.5 AdooQ BioScience Recent Developments/Updates
6.10 ProSpec
6.10.1 ProSpec Corporation Information
6.10.2 ProSpec Description and Business Overview
6.10.3 ProSpec Aprotinin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 ProSpec Aprotinin Product Portfolio
6.10.5 ProSpec Recent Developments/Updates
6.11 Yaxin Biotechnology
6.11.1 Yaxin Biotechnology Corporation Information
6.11.2 Yaxin Biotechnology Aprotinin Description and Business Overview
6.11.3 Yaxin Biotechnology Aprotinin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Yaxin Biotechnology Aprotinin Product Portfolio
6.11.5 Yaxin Biotechnology Recent Developments/Updates
6.12 AMRESCO
6.12.1 AMRESCO Corporation Information
6.12.2 AMRESCO Aprotinin Description and Business Overview
6.12.3 AMRESCO Aprotinin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 AMRESCO Aprotinin Product Portfolio
6.12.5 AMRESCO Recent Developments/Updates
6.13 PanReac AppliChem
6.13.1 PanReac AppliChem Corporation Information
6.13.2 PanReac AppliChem Aprotinin Description and Business Overview
6.13.3 PanReac AppliChem Aprotinin Sales, Revenue and Gross Margin (2019-2024)
6.13.4 PanReac AppliChem Aprotinin Product Portfolio
6.13.5 PanReac AppliChem Recent Developments/Updates
6.14 Runhao
6.14.1 Runhao Corporation Information
6.14.2 Runhao Aprotinin Description and Business Overview
6.14.3 Runhao Aprotinin Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Runhao Aprotinin Product Portfolio
6.14.5 Runhao Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aprotinin Industry Chain Analysis
7.2 Aprotinin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aprotinin Production Mode & Process
7.4 Aprotinin Sales and Marketing
7.4.1 Aprotinin Sales Channels
7.4.2 Aprotinin Distributors
7.5 Aprotinin Customers
8 Aprotinin Market Dynamics
8.1 Aprotinin Industry Trends
8.2 Aprotinin Market Drivers
8.3 Aprotinin Market Challenges
8.4 Aprotinin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
